Suppr超能文献

经皮肾细胞癌活检低估了核分级。

Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade.

机构信息

Department of Urology, Roswell Park Cancer Institute, Buffalo, New York, USA.

出版信息

Urology. 2010 Sep;76(3):610-3. doi: 10.1016/j.urology.2009.09.095. Epub 2010 Feb 16.

Abstract

OBJECTIVES

To assess the accuracy of renal biopsy for predicting the final nuclear grade and histologic subtype. Small renal masses can be safely observed in select patients who are poor surgical candidates. Renal biopsy may help identify patients who are candidates for observation.

METHODS

A total of 81 patients (29 female, 52 male) underwent percutaneous biopsy of their renal mass with ultrasound or computed tomography guidance. Percutaneous 18-gauge biopsy cores were obtained, and all patients subsequently underwent radical nephrectomy or partial nephrectomy. Preoperative biopsy results were compared with postoperative specimens.

RESULTS

The mean tumor size was 5.3 cm (range, 1-17). Overall, biopsy correctly identified 71 of 81 (88%) histologic subtypes. The preoperative biopsy correctly identified 62 of 64 (97%) clear cell renal carcinomas, 9 of 10 (90%) papillary carcinomas, 0 of 3 (0%) chromophobe carcinomas, and 1 of 2 (50%) oncocytomas. The final pathologies for 2 nondiagnostic biopsies were clear cell renal carcinoma and inflammatory pseudotumor. For 67 tumors, the pathologists assigned a nuclear grade for both the biopsy and the final specimen. The biopsy correctly identified 29 of 67 (43%) final nuclear grades. The biopsy underestimated the nuclear grade in 37 of 67 (55%) cases. In 7 of 67 (10%) cases, the biopsy nuclear grade increased by 2 when compared with the final grade. The biopsy rarely overestimated the nuclear grade; 1 case (1%) that was assigned a grade 2 on biopsy was assigned a grade 1 after nephrectomy.

CONCLUSIONS

Core biopsies for renal masses underestimate nuclear grade in most cases; however, histologic subtype is more reliably assessed, particularly for clear cell renal tumors.

摘要

目的

评估肾活检预测最终核分级和组织学亚型的准确性。对于选择的手术条件差的患者,可以安全地观察小的肾肿块。肾活检可以帮助确定适合观察的患者。

方法

共 81 例患者(29 例女性,52 例男性)接受超声或 CT 引导下经皮肾肿块活检。获得经皮 18 号活检芯,所有患者随后接受根治性肾切除术或部分肾切除术。比较术前活检结果与术后标本。

结果

平均肿瘤大小为 5.3cm(范围,1-17)。总的来说,活检正确识别了 81 例中的 71 例(88%)组织学亚型。术前活检正确识别了 64 例中的 62 例(97%)透明细胞肾细胞癌、10 例中的 9 例(90%)乳头状癌、3 例中的 0 例(0%)嫌色细胞癌和 2 例中的 1 例(50%)嗜酸细胞瘤。2 例非诊断性活检的最终病理分别为透明细胞肾细胞癌和炎性假瘤。对于 67 个肿瘤,病理学家对活检和最终标本均进行了核分级。活检正确识别了 67 例中的 29 例(43%)最终核分级。在 67 例中,活检核分级低估了 37 例(55%)。在 67 例中,活检核分级有 7 例(10%)与最终分级相比增加了 2 级。活检很少高估核分级;1 例(1%)活检分级为 2 级,肾切除后分级为 1 级。

结论

肾肿块的核心活检在大多数情况下低估了核分级;然而,组织学亚型的评估更为可靠,特别是对于透明细胞肾肿瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验